FDA Calls for Fall COVID Boosters , To Target Omicron Subvariants.
NBC News reports that on June 30,
the Food and Drug Administration asked vaccine makers to modify upcoming booster shots to target subvariants of Omicron.
The Omicron subvariants the agency wishes to target are BA.4 and BA.5.
Officials have called on vaccine makers Pfizer-BioNTech and Moderna to produce bivalent vaccines, .
which are intended to target the original strain of COVID-19 as well as its subvariants.
As we move into the fall
and winter, it is critical that
we have safe and effective vaccine boosters that can
provide protection... , Dr. Peter Marks, FDA, via NBC News.
... against circulating
and emerging variants to prevent the most severe consequences of COVID-19. , Dr. Peter Marks, FDA, via NBC News.
As of the week ending June 25, Omicron subvariants BA.4 and BA.5 were responsible for 52% of all new cases of COVID-19.
Per the Centers for Disease Control and Prevention, BA.1, the first variant of
Omicron, caused 0% of new cases.
Pfizer and Moderna have thus far
altered vaccines to target the
original strain of COVID-19 and BA.1.
which increased the immune response to earlier iterations, though both have waned in their efficacy against BA.4 and BA.5
Credit: Wibbitz Top Stories Duration: 01:30Published
Elmo Gets Vaccinated , Against COVID.
Earlier this month, Moderna and Pfizer/BioNTech vaccines were given emergency use authorization for children as young as six months old.
The CDC also signed off on
the shots for kids under 5.
On June 28, 'Sesame Street' issued a public service announcement to spread the word.
Elmo's dad, Louie, addressed
getting his son vaccinated.
Elmo's dad, Louie, addressed
getting his son vaccinated.
Was it safe? Was it the right decision?’ I talked to our pediatrician so I could make the right choice. I learned that Elmo getting vaccinated is the best way to keep himself, our friends, neighbors and everyone else healthy and enjoying the things they love, Louie, Elmo's dad, via 'Sesame Street'.
According to a Kaiser Family Foundation Vaccine Monitor survey conducted in April, 38% of parents wanted to
"wait and see" before vaccinating their young kids.
According to a Kaiser Family Foundation Vaccine Monitor survey conducted in April, 38% of parents wanted to
"wait and see" before vaccinating their young kids.
Jeanette Betancourt, senior vice president of U.S. social impact at Sesame Workshop, issued a statement about the PSA.
We hope that Louie and Elmo will inspire parents and caregivers across the country to speak with their healthcare providers and seek out information to learn about how the COVID-19 vaccines can keep young children and their families healthy, Jeanette Betancourt, senior vice president of U.S. social impact
at Sesame Workshop, via CNN.
The CDC reports that as of June 22, 30% of kids between the ages of 5 and 11 and 60% between the ages of 12 and 17 were fully vaccinated.
The CDC reports that as of June 22, 30% of kids between the ages of 5 and 11 and 60% between the ages of 12 and 17 were fully vaccinated
Credit: Wibbitz Top Stories Duration: 01:31Published
FDA Panel , Endorses
COVID Vaccines, for Children Under 5.
On June 15, an advisory panel to the United States
Food and Drug Administration voted to recommend
two COVID-19 vaccines for kids ages 5 and under.
Yahoo reports that both Pfizer/BioNTech
and Moderna were under review by the panel. .
The unanimous FDA panel vote
is the first step in what is predicted
to be a quick authorization process.
According to Yahoo, data from trials shows
that both vaccines continue to protect against severe disease, hospitalization and death.
According to Yahoo, data from trials shows
that both vaccines continue to protect against severe disease, hospitalization and death.
Yahoo reports that parents now
have two options for how
to vaccinate their children.
Pfizer's vaccine for kids is delivered in three,
three-microgram doses, while Moderna's vaccine
is delivered in two shots of a 25-microgram dose.
Our robust clinical study shows that
three doses can provide protection for
the circulating Omicron variant and
offers promise for protection against
potential future waves of COVID-19, Dr. Bill Gruber, Pfizer's Vaccine Clinical Research
and Development head, via Yahoo.
Our robust clinical study shows that
three doses can provide protection for
the circulating Omicron variant and
offers promise for protection against
potential future waves of COVID-19, Dr. Bill Gruber, Pfizer's Vaccine Clinical Research
and Development head, via Yahoo.
The committee’s support today
is imperative to providing a critical tool
for pediatricians, parents, and caregivers
who eagerly await an option
for children under five, Dr. Bill Gruber, Pfizer's Vaccine Clinical Research and Development head, via Yahoo.
Both companies are now awaiting approval from
the FDA and the CDC which will hold an advisory
committee meeting on the topic over the weekend.
Credit: Wibbitz Top Stories Duration: 01:30Published
Moderna Says New Booster , Shows 'Superior' Omicron Response.
NPR reports Moderna claims its most recent vaccine candidate has shown a "superior neutralizing
antibody response" when compared to its first vaccine.
It is "bivalent," engineered to
target two different antigens.
Per NPR, Moderna intends to make its
newest booster available in fall 2022.
We are submitting our
preliminary data and analysis to regulators with the hope that the Omicron-containing bivalent booster will be available in the late summer. , Stéphane Bancel, Moderna CEO, via statement.
Due to a higher antibody response, Moderna believes its newest vaccine will offer protection that is "more durable over time" against Omicron.
Due to a higher antibody response, Moderna believes its newest vaccine will offer protection that is "more durable over time" against Omicron.
Moderna officials think their new vaccine could potentially offer protection for one year.
As new variants continuously arise, Moderna officials
hope the new bivalent vaccine can counter the
more contagious strains taking hold in the United States.
As new variants continuously arise, Moderna officials
hope the new bivalent vaccine can counter the
more contagious strains taking hold in the United States.
According to the Centers for Disease
Control and Prevention (CDC), two new
subvariants of Omicron, BA.4 and BA.5,
are spreading quickly across the country.
Experts say another wave of coronavirus
is bound to occur next winter as cold weather drives citizens back indoors
Credit: Wibbitz Top Stories Duration: 01:30Published
As the cases of the Covid-19 virus are once again on the rise in the country an Israeli health expert on Sunday said that India has a new sub-variant of the highly contagious Omicron lineage of coronavirus, BA.2.75.
#Omicron #OmicronSubvariant #Covid-19inIndia
Many European countries are experiencing a surge in new COVID-19 infections, with the more transmissible Omicron subvariant BA.5 spreading across the continent.
Credit: euronews (in English) Duration: 01:55Published
Pfizer Says Updated COVID-19 Shot , Effective Against Omicron.
NBC News reports Pfizer announced on
June 25 that its updated coronavirus vaccine
better targets the omicron variant.
Experts say while current vaccines offer ample protection against new variants, .
their effectiveness has waned
in the age of omicron.
The Food and Drug Administration has considered ordering altered vaccines, .
hoping a modified recipe could offer
more protection when coronavirus
surges again this fall and winter.
Pfizer says after studying over 1,200 adults who had received three vaccine doses.
officials say each of their vaccines
showed a substantial increase in omicron-resistant antibodies.
Based on these data,
we believe we have two
very strong omicron-
adapted candidates. , statement from Pfizer CEO Albert Bourla, via NBC News.
Pfizer's tweaked shot shows a 9 to 11-fold increase in omicron-fighting antibodies.
almost 1.5 times higher than
the company's initial dose
Credit: Wibbitz Top Stories Duration: 01:30Published
Pfizer's COVID Vaccine
for Kids Under 5 , Moves Closer to FDA Approval .
Pfizer announced on June 1 that its application to the Food and Drug Administration (FDA) for the vaccine was complete.
Pfizer announced on June 1 that its application to the Food and Drug Administration (FDA) for the vaccine was complete.
The three-dose vaccine is for children between the ages of six months and five years.
Pfizer released a statement detailing the application.
Pfizer and BioNTech completed a rolling application to the U.S. Food and Drug Administration (FDA) for emergency use authorization (EUA)... , Pfizer Statement, via ABC News.
... of the 3-µg [microgram] dose of the Pfizer-BioNTech COVID-19 Vaccine.., Pfizer Statement, via ABC News.
... for children 6 months through
4 years of age (also referred to as
6 months to under 5 years of age) on June 1, 2022, Pfizer Statement, via ABC News.
Pfizer reported an 80 percent effectiveness rate in children in May.
The FDA also released a statement on June 1, confirming that the agency had accepted the Pfizer application.
We recognize parents are anxious to have their young children vaccinated against COVID-19... , FDA Statement, via ABC News.
... and while the FDA cannot predict how long its evaluation of the data and information
will take, , FDA Statement, via ABC News.
... we will review any EUA request we receive as quickly as possible using a science-based approach, FDA Statement, via ABC News.
According to a poll conducted by the
Kaiser Family Foundation in April of this year.
... just 18 percent of parents intend to have their children vaccinated once the vaccine is approved.
27 percent of parents stated that they will "definitely not" vaccinate their children against COVID
Credit: Wibbitz Top Stories Duration: 01:31Published
FDA Panel, Meets to Determine, COVID Booster Shot Strategy.
FDA Panel, Meets to Determine, COVID Booster Shot Strategy.
On April 6, United States Food and Drug Administration, advisers will meet to..
Credit: Wibbitz Top Stories Duration: 01:31Published
What's Next for , COVID-19 Vaccines?.
NPR reports most vaccinated
Americans will soon be up for another
round of coronavirus shots.
Experts say as autumn approaches,
immunity could be waning among..
Credit: Wibbitz Top Stories Duration: 01:30Published
![FDA Calls for Fall COVID Boosters To Target Omicron Subvariants [Video]](https://video.newsserve.net/300/v/20220630/1337931914-FDA-Calls-for-Fall-COVID-Boosters-To-Target.jpg)
![Elmo Gets Vaccinated Against COVID [Video]](https://video.newsserve.net/300/v/20220628/1337835297-Elmo-Gets-Vaccinated-Against-COVID.jpg)
![FDA Panel Endorses COVID Vaccines for Children Under 5 [Video]](https://video.newsserve.net/300/v/20220616/1337268496-FDA-Panel-Endorses-COVID-Vaccines-for-Children-Under.jpg)
![Moderna Says New Booster Shows 'Superior' Omicron Response [Video]](https://video.newsserve.net/300/v/20220608/1336893585-Moderna-Says-New-Booster-Shows-Superior-Omicron-Response.jpg)
![New sub-variant of Omicron detected in 10 Indian states, alerts Israeli expert | Oneindia News *News [Video]](https://video.newsserve.net/300/v/20220705/1338089650-New-sub-variant-of-Omicron-detected-in-10.jpg)
!['We should not be complacent' over COVID-19 rise on the continent, WHO Europe chief says [Video]](https://video.newsserve.net/300/v/20220701/1337967059-We-should-not-be-complacent-over-COVID-19.jpg)
![Pfizer Says Updated COVID-19 Shot Effective Against Omicron [Video]](https://video.newsserve.net/300/v/20220627/1337781797-Pfizer-Says-Updated-COVID-19-Shot-Effective-Against.jpg)
![Pfizer's COVID Vaccine for Kids Under 5 Moves Closer to FDA Approval [Video]](https://video.newsserve.net/300/v/20220602/1336550862-Pfizer-COVID-Vaccine-for-Kids-Under.jpg)
![FDA Panel Meets to Determine COVID Booster Shot Strategy [Video]](https://video.newsserve.net/300/v/20220406/1333955173-FDA-Panel-Meets-to-Determine-COVID-Booster-Shot.jpg)
![What's Next for COVID-19 Vaccines? [Video]](https://video.newsserve.net/300/v/20220405/1333898331-What-Next-for-COVID-19-Vaccines.jpg)
